SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 22.65 |
| Enterprise Value ($M) | 18.59 |
| Book Value ($M) | 3.82 |
| Book Value / Share | 0.44 |
| Price / Book | 5.93 |
| NCAV ($M) | 3.82 |
| NCAV / Share | 0.44 |
| Price / NCAV | 5.93 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.65 |
| Return on Assets (ROA) | -2.37 |
| Return on Equity (ROE) | -2.54 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.90 |
| Current Ratio | 5.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.60 |
| Assets | 4.60 |
| Liabilities | 0.78 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Empery Asset Management, LP |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 70,549 | 282,655 | 24.96 | |
| 276,738 | 775,555 | 35.68 | |
| 905,353 | 2,514,616 | 36.00 | |
| 323,023 | 737,263 | 43.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BCDA – BioCardia, Inc. | BCLI – Brainstorm Cell Therapeutics Inc. |
| BCTX – BriaCell Therapeutics Corp. | BFRI – Biofrontera Inc. |
| BGM – BGM Group Ltd. |
Financial data and stock pages provided by
Fintel.io